Piperacillin-tazobactam shortage ‘serious’, says RPS spokesperson

2 July 2017: Philip Howard, Royal Pharmaceutical Society (RPS) spokesman on antimicrobial resistance, gave a comment to The Observer about the shortage of piperacillin-tazobactam, a combination antibiotic widely used in hospitals. “This is one of the more serious shortages we’ve had to face,” Howard said, although he added that there were enough supplies of other drugs for patients to get the treatment they needed. He also warned that “we need to ensure that we use a broader range of antibiotics in our hospitals, so that if there is a global supply problem, it doesn’t have such a large impact.”

Last updated
The Pharmaceutical Journal, Piperacillin-tazobactam shortage 'serious', says RPS spokesperson;Online:DOI:10.1211/PJ.2017.20203131

You may also be interested in